Stocks · Health care · Biological Products, (No Diagnostic Substances)

Taysha Gene Therapies, Inc.

TSHA Clue Score55
United States Fiscal year ends December CIK 0001806310 Results filed 11 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Sukumar Nagendran
10 Jul 2026
President and Head of R&D
Sold on a plan
200,000
$6.24
$1.25M

What was left out

Form 4 filings counted 14
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 4
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 2,468,533
History held since 25 Sep 2020